Colombo: A study conducted in our neighboring Sri Lanka on the covishield vaccine has yielded shocking results. In fact, the study has shown that single doses of covishield begin to reduce after 16 weeks in people above 60 years of age. On the other hand, the impact of a single dose of this vaccine on youth is effective up to 93 percent. The study has been conducted at Colombo University. Tell us that the vaccine is administered in India under the name Covishield is a vaccine manufactured by Oxford and AstraZeneca and is produced by the Serum Institute of India.
Neelika Malavige, professor of immunology and molecular sciences at Jayawardenepura University in Colombo, tweeted about the results of the study, in which she said that 16 weeks after a 60-year-old person has a single dose, the effectiveness of the vaccine begins to decline. However, the effect of the vaccine has been very good in the elderly. Even after 16 weeks, 93 percent of the antibodies have been observed in elderly persons.
Prof. Neelika Malavige has said that our study has appeared in nature comms. He said that after taking a single dose of covishield, 93.4 percent of the individuals showed antibody levels of up to 97.1 percent.